The Central Drugs Standard Organisation (CDSO) has approved the shelf life of COVID-19 vaccines Covaxin to 12 months, Covishield to nine months, and ZyCoV-D to six months from the date of manufacture, the Lok Sabha was informed on Friday.
NITI Aayog's Dr VK Paul on Thursday said the Centre's first priority is to complete the task of vaccinating all adults with both doses of COVID-19 vaccine. Regarding providing a booster dose to fully vaccinated individuals, he said it is under consideration.
As Omicron fear intensifies, Serum Institute of India seeks DCGI s approval for Covishield booster shot - Recently, Kerala, Rajasthan, Karnataka, and Chhattisgarh have also urged the Centre to decide on allowing booster doses of the COVID-19 vaccine.
The Serum Institute of India (SII) has sought India drug regulator approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccin
The Serum Institute of India (SII) has sought India drug regulator approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccin
The Serum Institute of India (SII) has sought India drug regulator approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccin
The Serum Institute of India (SII) has sought India drug regulator approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccin
The Serum Institute of India (SII) has sought India drug regulator approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccin
The Serum Institute of India (SII) has sought India drug regulator approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccin